APA (7th ed.) Citation

Wang, C., Liao, K., Wang, Y., Chen, K., Chuang, S., Liu, C., . . . Wang, H. (2023). Dipeptidyl peptidase IV inhibitors and the risk of mycobacterial pulmonary infections in type 2 diabetes mellitus. Elsevier.

Chicago Style (17th ed.) Citation

Wang, Cheng-Yi, Kuang-Ming Liao, Ya-Hui Wang, Kuang-Hung Chen, Shulin Chuang, Chia-Jung Liu, Chin-Chung Shu, and Hao-Chien Wang. Dipeptidyl Peptidase IV Inhibitors and the Risk of Mycobacterial Pulmonary Infections in Type 2 Diabetes Mellitus. Elsevier, 2023.

MLA (9th ed.) Citation

Wang, Cheng-Yi, et al. Dipeptidyl Peptidase IV Inhibitors and the Risk of Mycobacterial Pulmonary Infections in Type 2 Diabetes Mellitus. Elsevier, 2023.